loadpatents
Patent applications and USPTO patent grants for Drucker; Daniel J..The latest application filed is for "method of regulating glucose metabolism, and reagents related thereto".
Patent | Date |
---|---|
Method of Regulating Glucose Metabolism, and Reagents Related Thereto App 20160000857 - Bachovchin; William W. ;   et al. | 2016-01-07 |
Methods for treating disorders of the gastrointestinal tract using a GLP-1 agonist Grant 9,168,288 - Drucker , et al. October 27, 2 | 2015-10-27 |
Methods Of Enhancing Functioning Of The Large Intestine App 20150290295 - Drucker; Daniel J. | 2015-10-15 |
Methods of regulating glucose metabolism, and reagents related thereto Grant 9,044,424 - Bachovchin , et al. June 2, 2 | 2015-06-02 |
Glucagon-like peptide-2 analogs Grant 8,933,039 - Drucker , et al. January 13, 2 | 2015-01-13 |
Glucagon-like peptide-2 analogs Grant 8,846,625 - Drucker , et al. September 30, 2 | 2014-09-30 |
Methods Of Enhancing Functioning Of The Large Intestine App 20140213518 - Drucker; Daniel J. | 2014-07-31 |
Methods of Regulating Glucose Metabolism, and Reagents Related Thereto App 20140178472 - Bachovchin; William W. ;   et al. | 2014-06-26 |
Methods of enhancing functioning of the large intestine Grant 8,603,976 - Drucker December 10, 2 | 2013-12-10 |
Method of regulating glucose metabolism, and reagents related thereto Grant 8,513,190 - Bachovchin , et al. August 20, 2 | 2013-08-20 |
Glucagon-like Peptide-2 Analogs App 20130203673 - Drucker; Daniel J. ;   et al. | 2013-08-08 |
Methods for Treating Disorders of the Gastrointestinal Tract Using a GLP-1 Agonist App 20130053316 - Drucker; Daniel J. ;   et al. | 2013-02-28 |
Methods Of Enhancing Functioning Of The Large Intestine App 20120328527 - Drucker; Daniel J. | 2012-12-27 |
Method of regulating glucose metabolism, and reagents related thereto Grant 8,318,669 - Bachovchin , et al. November 27, 2 | 2012-11-27 |
Methods of enhancing functioning of the large intestine Grant 8,278,273 - Drucker October 2, 2 | 2012-10-02 |
Method of Regulating Glucose Metabolism, and Reagents Related Thereto App 20120165252 - Bachovchin; William W. ;   et al. | 2012-06-28 |
Methods Of Enhancing Functioning Of The Large Intestine App 20110275568 - Drucker; Daniel J. | 2011-11-10 |
Glucagon-like Peptide-2 And Its Therapeutic Use App 20110223108 - Drucker; Daniel J. | 2011-09-15 |
Methods of enhancing functioning of the large intestine Grant 7,960,344 - Drucker June 14, 2 | 2011-06-14 |
Glucagon-like peptide-2 and its therapeutic use Grant 7,888,317 - Drucker February 15, 2 | 2011-02-15 |
Glucagon-like Peptide-2 Analogs App 20110009320 - Drucker; Daniel J. ;   et al. | 2011-01-13 |
Enhancement of GLP-2 activity of suppressing appetite Grant 7,862,824 - Drucker , et al. January 4, 2 | 2011-01-04 |
Glucagon-like peptide-2 analogs Grant 7,781,401 - Drucker , et al. August 24, 2 | 2010-08-24 |
Methods Of Enhancing Functioning Of The Large Intestine App 20100119453 - Drucker; Daniel J. | 2010-05-13 |
Methods of enhancing functioning of the large intestine Grant 7,642,241 - Drucker January 5, 2 | 2010-01-05 |
Methods of enhancing functioning of the large intestine App 20070129304 - Drucker; Daniel J. | 2007-06-07 |
Methods of enhancing functioning of the large intestine Grant 7,176,182 - Drucker February 13, 2 | 2007-02-13 |
GLP-2 receptor gene promoter and uses thereof App 20070033662 - Drucker; Daniel J. ;   et al. | 2007-02-08 |
Glucagon-like peptide-2 and its therapeutic use Grant 7,049,284 - Drucker May 23, 2 | 2006-05-23 |
Glucagon-like peptide-2 and its therapeutic use App 20060105954 - Drucker; Daniel J. | 2006-05-18 |
Enhancement of GLP-2 activity App 20040198642 - Drucker, Daniel J. ;   et al. | 2004-10-07 |
Ampk-related serine/threonine kinase, designated snark App 20040132025 - Drucker, Daniel J. ;   et al. | 2004-07-08 |
Polynucleotides encoding proexendin, and methods and uses thereof Grant 6,723,530 - Drucker April 20, 2 | 2004-04-20 |
Methods of enhancing functioning of the large intestine App 20030207809 - Drucker, Daniel J. | 2003-11-06 |
Glucagon-like peptide-2 analogs App 20030162703 - Drucker, Daniel J. ;   et al. | 2003-08-28 |
Glucagon-like peptide-2 and its therapeutic use App 20030158101 - Drucker, Daniel J. | 2003-08-21 |
Methods of enhancing functioning of the large intestine Grant 6,586,399 - Drucker July 1, 2 | 2003-07-01 |
Antagonists of intestinotrophic GLP-2 peptides App 20030109449 - Drucker, Daniel J. ;   et al. | 2003-06-12 |
Chemotherapy treatment App 20030040478 - Drucker, Daniel J ;   et al. | 2003-02-27 |
Antagonists of intestinotrophic GLP-2 peptides Grant 6,489,295 - Drucker , et al. December 3, 2 | 2002-12-03 |
Enhancement of GLP-2 activity App 20020123461 - Drucker, Daniel J. ;   et al. | 2002-09-05 |
GLP-2 receptor gene promoter and uses thereof App 20020045173 - Drucker, Daniel J. ;   et al. | 2002-04-18 |
Methods of enhancing functioning of the large intestine Grant 6,297,214 - Drucker October 2, 2 | 2001-10-02 |
Glucagon-like peptide-2 analogs App 20010021767 - Drucker, Daniel J. ;   et al. | 2001-09-13 |
Intestinotrophic glucagon-like peptide-2 analogs Grant 6,184,201 - Drucker , et al. February 6, 2 | 2001-02-06 |
Methods of enhancing functioning of the upper gastrointestinal tract Grant 6,051,557 - Drucker April 18, 2 | 2000-04-18 |
Antagonists of intestinotrophic GLP-2 peptides Grant 5,994,500 - Drucker , et al. November 30, 1 | 1999-11-30 |
Glucagon-like peptide-2 and its therapeutic use Grant 5,990,077 - Drucker November 23, 1 | 1999-11-23 |
Method of using exendin and GLP-1 to affect the central nervous system Grant 5,846,937 - Drucker December 8, 1 | 1998-12-08 |
Glucagon-like peptide-2 and its therapeutic use Grant 5,834,428 - Drucker November 10, 1 | 1998-11-10 |
Glucagon-like peptide-2 analogs Grant 5,789,379 - Drucker , et al. August 4, 1 | 1998-08-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.